Losses
-€89,180 in two years
The 2024 and 2025 financial years closed with a loss. 2025 was the heaviest.
DEROMLA
Lifetime
10 annual accounts with figures on one time axispeak €167,959 (2025)
€167,959▲ 0.5%
lowest -€47,707 (2025)
-€47,707▼ €6,234
peak €374,007 (2021)
€279,333▼ 14.6%
€1.3m▲ 0.3%
peak 1.6 FTE (2021)
-not published
Board2 names since 2025
2 directorsMadame DEMANET Emilie Marie and 1 other
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Gross margin from €60,728 to €81,555Loss of €47,707Resignation: DEMANET Emilie Marie (manager) 21-11Equity from €327,040 to €279,333Cash from €6,195 to €2,063
Key points
from the 2025 annual accountsDebts
€1.3m 83% of the balance sheet
Financial debts 33%Suppliers 8%Taxes and wages 1%Other 58%
Of this, €594,827 falls due within a year.
Payment terms
433 days to suppliers
DEROMLA pays its suppliers 96 days later than in 2024. Customers pay 45 days earlier.
2025 accounts filed 61 days after the deadline
Checked score
50
Fair
Financially stronger than 29% of micro companies in other manufacturing (NACE 32)
Probability in this band: 1.5% to 4.2%
Bankruptcy probability within 12 months
2.7% Moderate
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.3% across 1,141 companies (NACE 32, micro).
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 1.7%
01-2025: 1.7%● unchanged vs 12-2024
02-2025: 1.7%● unchanged vs 01-2025
03-2025: 1.8%▲ +0.1 percentage points vs 02-2025
04-2025: 1.8%● unchanged vs 03-2025
05-2025: 1.7%▼ -0.1 percentage points vs 04-2025
06-2025: 1.7%● unchanged vs 05-2025
07-2025: 1.7%● unchanged vs 06-2025
08-2025: 1.9%▲ +0.2 percentage points vs 07-2025
09-2025: 2.1%▲ +0.2 percentage points vs 08-2025
10-2025: 3.3%▲ +1.2 percentage points vs 09-2025
11-2025: 1.4%▼ -1.9 percentage points vs 10-2025lowest value
12-2025: 2.1%▲ +0.7 percentage points vs 11-2025
01-2026: 2.2%▲ +0.1 percentage points vs 12-2025
02-2026: 2.1%▼ -0.1 percentage points vs 01-2026
03-2026: 2.2%▲ +0.1 percentage points vs 02-2026
04-2026: 2.3%▲ +0.1 percentage points vs 03-2026
05-2026: 2.4%▲ +0.1 percentage points vs 04-2026
06-2026: 2.2%▼ -0.2 percentage points vs 05-2026
07-2026: 2.4%▲ +0.2 percentage points vs 06-2026
08-2026: 2.8%▲ +0.4 percentage points vs 07-2026
09-2026: 3.5%▲ +0.7 percentage points vs 08-2026highest value
10-2026: 2.7%▼ -0.8 percentage points vs 09-2026
11-2026: 2.7%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Last filed accounts filed 61 days late; 3 of the last 3 accounts late
Liquidity: current ratio 2.01, cash €2,063, halved
1 change of registered office in 24 months
lowers risk
Size: turnover €167,959, total assets €1.6m
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 29% of them on solvency, 25% on liquidity, 20% on profitability and 43% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the moderate class on 30-06-2025, 2.4% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 2,166 companies had the same profile as DEROMLA has now. Each dot stands for 6 companies, two years later.
94.2%
were still trading
3.0%
stopped another way
2.5%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of DEROMLA itself: 2.7% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,166 companies, not a prediction for DEROMLA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €13,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.01 (2.09 in 2024), above the usual 1.5. Short-term debt is 36.6% and cash 0.1% of total assets. However, 82.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€47,707
raises risk · 2025 accounts filed 61 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-09-2026, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
61 days late
2024
81 days late
2023
62 days late
2022
28 days late
2021
40 days late
2020
19 days late
2019
87 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 54 days after the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 September (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Resignation: DEMANET Emilie Marie (manager)
Reappointment: DEMANET Emilie Marie (director) · “La fabrication et la vente d'appareils orthopédiques et de prothèse,ceintures médicales et chaussures…” (deed in French) · Director discharge: DEMANET Emilie Marie · General meeting of 12-11-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0643716348
Incorporation
published on 02-12-2015 · Gazette deed
First establishment
Rue des Haies 135-137, Charleroi
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DEROMLA Charleroi | €1.6m | €81,555 | 17.2% | - |
| GLAUKOS BELGIUM Sint-Gillis (bij-Brussel) | €1.0m | €59,399 | 11.3% | - |
| ORTHOPEDIE MERGAUX S.P.R.L. Habay | €1.5m | €160,853 | 75.7% | - |
| ORTHOPRO Morlanwelz | €1.1m | €103,825 | 25.4% | - |
| Tita-Link Woluwe-Saint-Pierre | €1.7m | €219,369 | 19.3% | 1 |
| ORTHOPEDICO Geel | €1.0m | €131,487 | 86.6% | - |
| VERACHTERT DIGITAL Antwerp | €1.1m | €132,559 | 96.2% | 1.6 |
These companies have the same main activity as DEROMLA: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €956,000 and €1.7m, founded between 2007 and 2017.
Official details
Source: KBO- Status
- Active since 30-11-2015Normal situation
- Activity
- Manufacture of medical and dental instruments and suppliesNACE 32500and 2 others
- Establishment unit
- 2.249.486.0226001 Charleroi, since 30-11-2015
- Financial year end
- 31 December
- Peppol
- Reachable since 12-08-2025
Insights on DEROMLA
DEROMLA has existed since 2015. Turnover grew from €456 in 2016 to €167,959 in 2025.
Turnover has grown every year since 2022.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DEROMLA
- What is the company number of DEROMLA?
- The company number of DEROMLA is 0643.716.348. The VAT number is the same number with BE in front: BE 0643.716.348.
- Where is DEROMLA based?
- The registered office is at Rue des Haies 135-137, 6001 Charleroi.Company details
- What does DEROMLA do?
- According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
- What is the legal form of DEROMLA?
- DEROMLA is a private limited company (BV).
- When was DEROMLA founded?
- DEROMLA was founded on 30-11-2015.
- Is DEROMLA still active?
- Yes, DEROMLA is an active enterprise in the KBO register.
- How many employees does DEROMLA have?
- DEROMLA had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of DEROMLA?
- The turnover of DEROMLA was €167,959 in financial year 2025, according to the filed annual accounts.
- Is DEROMLA profitable?
- In financial year 2025, DEROMLA made a loss of €47,707.
- Where can I find the annual accounts of DEROMLA?
- DEROMLA filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DEROMLA due?
- DEROMLA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.